Early outpatient administration of Remdesivir shortens recovery time in patients with mild to moderate COVID-19
Background During COVID-19, healthcare systems in underdeveloped nations had significant challenges and were unlikely to offer the necessary care. It appears that a new, reliable healthcare model that prevents hospitalization is necessary to reduce the pressure that COVID-19 is putting on healt...
Main Authors: | Majid Hajimaghsoudi, Fatemeh Saghafi, Mahya Shorabi, Samaneh Mirzaei, Mehrnaz Moharami, Negin Daryaei, Farahnaz Hoseinzade, Farzad Jalili, Hamid Reza Rezaei, Yekta Rameshi, Mohsen Gholinataj Jelodar |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2023-12-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/602 |
Similar Items
-
Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience
by: Irene Pereta, et al.
Published: (2023-02-01) -
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
by: Samuel M. Brown, et al.
Published: (2023-04-01) -
The use of Remdesivir in pregnant women with COVID-19
by: Gulbanu Shaimerdenova, et al.
Published: (2023-02-01) -
Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center
by: Mahendra Munirathnam, et al.
Published: (2021-01-01) -
Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
by: Flor álvarez de Toledo
Published: (2020-10-01)